Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease.
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
Devic's disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874).
Association of sex hormones and glucose metabolism with the severity of multiple sclerosis.
Implications of water channel proteins in selected neurological disorders: Epilepsies, muscular dystrophies, amyotrophic lateral sclerosis, neuromyelitis optica, Parkinson's disease, and spongiform encephalopathies.
Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
2010 McDonald criteria for diagnosing pediatric multiple sclerosis.
[Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease].
The onset location of neuromyelitis optica spectrum disorder predicts the location of subsequent relapses.
So many progenitors, so little myelin.
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.
Self-rating makes the difference: Identifying palliative care needs of patients feeling severely affected by multiple sclerosis.
A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.
Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study.
Linkage of multiple sclerosis and guillain-barre syndrome: a population-based survey in isfahan, iran.
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses.
Sexual disparities in the incidence and course of MS.
STAT3 Activates miR-155 in Th17 cells and Acts in Concert to Promote Experimental Autoimmune Uveitis.
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: Insights from genomic-wide association studies.
Influence of Peripheral inflammation on the progression of Multiple Sclerosis: Evidence from the clinic and experimental animal models.
Activities-specific balance confidence in people with multiple sclerosis.
Social and economic burden of walking and mobility problems in multiple sclerosis.
Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β
Gait and six-minute walk performance in persons with multiple sclerosis.
Pages
« first
‹ previous
…
336
337
338
339
340
341
342
343
344
…
next ›
last »